SMART Trial: Community Stigma Reduction

Opioid-use Disorder Clinical Trial

Official title:

SMART Trial: Reducing Stigma Towards Opioid Use Disorder at the Community Level

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05075330
• Other study ID #: 21-08181-XP
• Status: Completed
• Phase: N/A
• Start date: June 16, 2021
• Est. completion date: August 19, 2021

Study information

• Verified date: March 2022
• Source: University of Tennessee
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this project is to engage community members from two low-income African American communities (N=200) in a survey study that assesses stigma toward those with Opioid Use Disorder (OUD). Those from the intervention community will be subject to a stigma reduction campaign via billboards. Those from the control community will not. Stigma will be re-assessed following the period of the campaign.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 199
• Est. completion date: August 19, 2021
• Est. primary completion date: August 19, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Identify as African American or Mixed race

• Reside in Frayser or Orange Mound Communities

• Access to telephone for follow-up assessment

Exclusion Criteria:

• Unable to understand consent procedures

Related Conditions & MeSH terms

• Opioid-Related Disorders
• Opioid-use Disorder
• Stigma, Social
• Substance-Related Disorders

Intervention

Behavioral:
• Opioid Use Disorder Stigma Reduction
Billboards with destigmatizing language regarding opioid use disorder placed in the community.

Locations

Country	Name	City	State
United States	University of Tennessee Health Science Center	Memphis	Tennessee

Sponsors (2)

Lead Sponsor	Collaborator
Karen Derefinko, PhD	National Center for Complementary and Integrative Health (NCCIH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Stigma score	Pre- and post-intervention stigma assessments using the Exposure to Drug Users Index, Drug Use Stigmatization Scale, and the Stigma of Drug Users Scale	Change from baseline stigma score at 8 weeks